919 related articles for article (PubMed ID: 33166939)
21. Gut-microbiota derived bioactive metabolites and their functions in host physiology.
Debnath N; Kumar R; Kumar A; Mehta PK; Yadav AK
Biotechnol Genet Eng Rev; 2021 Oct; 37(2):105-153. PubMed ID: 34678130
[TBL] [Abstract][Full Text] [Related]
22. Dysbiosis in gastrointestinal disorders.
Chang C; Lin H
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):3-15. PubMed ID: 27048892
[TBL] [Abstract][Full Text] [Related]
23. Gut dysbacteriosis and intestinal disease: mechanism and treatment.
Meng X; Zhang G; Cao H; Yu D; Fang X; de Vos WM; Wu H
J Appl Microbiol; 2020 Oct; 129(4):787-805. PubMed ID: 32277534
[TBL] [Abstract][Full Text] [Related]
24. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
[TBL] [Abstract][Full Text] [Related]
25. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
[TBL] [Abstract][Full Text] [Related]
26. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
27. Prebiotic effects: metabolic and health benefits.
Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
[TBL] [Abstract][Full Text] [Related]
28. Gut Microbiota and Their Associated Metabolites in Diabetes: A Cross Talk Between Host and Microbes-A Review.
Safari-Alighiarloo N; Emami Z; Rezaei-Tavirani M; Alaei-Shahmiri F; Razavi S
Metab Syndr Relat Disord; 2023 Feb; 21(1):3-15. PubMed ID: 36301254
[TBL] [Abstract][Full Text] [Related]
29. Microbial interactions and the homeostasis of the gut microbiome: the role of
Martin AJM; Serebrinsky-Duek K; Riquelme E; Saa PA; Garrido D
Microbiome Res Rep; 2023; 2(3):17. PubMed ID: 38046822
[TBL] [Abstract][Full Text] [Related]
30. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
[TBL] [Abstract][Full Text] [Related]
31. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
32. Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis.
Bull MJ; Plummer NT
Integr Med (Encinitas); 2015 Feb; 14(1):25-33. PubMed ID: 26770128
[TBL] [Abstract][Full Text] [Related]
33. The mutual interplay of gut microbiota, diet and human disease.
Illiano P; Brambilla R; Parolini C
FEBS J; 2020 Mar; 287(5):833-855. PubMed ID: 31955527
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiome and type 2 diabetes: where we are and where to go?
Sharma S; Tripathi P
J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
[TBL] [Abstract][Full Text] [Related]
35. Host-Microbiota Interaction and Intestinal Epithelial Functions under Circadian Control: Implications in Colitis and Metabolic Disorders.
Huang YJ; Pai YC; Yu LC
Chin J Physiol; 2018 Dec; 61(6):325-340. PubMed ID: 30580502
[TBL] [Abstract][Full Text] [Related]
36. Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis.
Carco C; Young W; Gearry RB; Talley NJ; McNabb WC; Roy NC
Front Cell Infect Microbiol; 2020; 10():468. PubMed ID: 33014892
[TBL] [Abstract][Full Text] [Related]
37. Role of gut microbiota-derived signals in the regulation of gastrointestinal motility.
Zheng Z; Tang J; Hu Y; Zhang W
Front Med (Lausanne); 2022; 9():961703. PubMed ID: 35935766
[TBL] [Abstract][Full Text] [Related]
38. Gut microbiota in autoimmunity: potential for clinical applications.
Kim D; Yoo SA; Kim WU
Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
[TBL] [Abstract][Full Text] [Related]
39. Rebuilding the Gut Microbiota Ecosystem.
Gagliardi A; Totino V; Cacciotti F; Iebba V; Neroni B; Bonfiglio G; Trancassini M; Passariello C; Pantanella F; Schippa S
Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30087270
[TBL] [Abstract][Full Text] [Related]
40. Targeting gut microbiota as a possible therapy for diabetes.
He C; Shan Y; Song W
Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
